Mishima Eikan, Conrad Marcus
Institute of Metabolism and Cell Death, Helmholtz Zentrum München, Neuherberg, Germany; email:
Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Annu Rev Nutr. 2022 Aug 22;42:275-309. doi: 10.1146/annurev-nutr-062320-114541. Epub 2022 Jun 1.
Ferroptosis is a type of regulated cell death characterized by an excessive lipid peroxidation of cellular membranes caused by the disruption of the antioxidant defense system and/or an imbalanced cellular metabolism. Ferroptosis differentiates from other forms of regulated cell death in that several metabolic pathways and nutritional aspects, including endogenous antioxidants (such as coenzyme Q, vitamin E, and di/tetrahydrobiopterin), iron handling, energy sensing, selenium utilization, amino acids, and fatty acids, directly regulate the cells' sensitivity to lipid peroxidation and ferroptosis. As hallmarks of ferroptosis have been documented in a variety of diseases, including neurodegeneration, acute organ injury, and therapy-resistant tumors, the modulation of ferroptosis using pharmacological tools or by metabolic reprogramming holds great potential for the treatment of ferroptosis-associated diseases and cancer therapy. Hence, this review focuses on the regulation of ferroptosis by metabolic and nutritional cues and discusses the potential of nutritional interventions for therapy by targeting ferroptosis.
铁死亡是一种受调控的细胞死亡类型,其特征是由于抗氧化防御系统的破坏和/或细胞代谢失衡导致细胞膜脂质过氧化过度。铁死亡与其他形式的受调控细胞死亡不同,在于包括内源性抗氧化剂(如辅酶Q、维生素E和二氢/四氢生物蝶呤)、铁代谢、能量感应、硒利用、氨基酸和脂肪酸在内的几种代谢途径和营养方面直接调节细胞对脂质过氧化和铁死亡的敏感性。由于铁死亡的特征已在多种疾病中得到记录,包括神经退行性疾病、急性器官损伤和耐药肿瘤,使用药理学工具或通过代谢重编程来调节铁死亡在治疗铁死亡相关疾病和癌症治疗方面具有巨大潜力。因此,本综述重点关注代谢和营养线索对铁死亡的调控,并讨论通过靶向铁死亡进行营养干预治疗的潜力。